Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19
BackgroundChronic obstructive pulmonary disease (COPD) is associated with increased risk of severe COVID-19, but the mechanisms are unclear. Besides, patients with severe COVID-19 have been reported to have increased levels of several immune mediators.MethodsNinety-two proteins were quantified in 31...
Main Authors: | Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, Rodolfo Dennis, Carlos A. Torres-Duque, Luis Caraballo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.678661/full |
Similar Items
-
Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice
by: Daisuke Morichika, et al.
Published: (2021-05-01) -
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
by: Mark M. Perry, et al.
Published: (2018-05-01) -
Platelet Interactions with Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells Lead to Hepatocyte Proliferation
by: Jeremy Meyer, et al.
Published: (2020-05-01) -
The Incremental Prognostic Value of Hepatocyte Growth Factor in First-Ever Acute Ischemic Stroke: An Early Link Between Growth Factor and Interleukins
by: Fangfang Li, et al.
Published: (2021-08-01) -
Liver Regeneration and Immunity: A Tale to Tell
by: Nicola Di-Iacovo, et al.
Published: (2023-01-01)